Welcome to light therapy Guide
Fda Approved Light Therapy Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
from: Light Box Therapy--A Favorite Light Therapy ProductThere are several types of light therapy products, with the Light Box Therapy fast becoming one of the favorites, especially in the treatment of depression. Not acceptable in the past 25 years, antidepressant medication and psychotherapy have taken the front seat for acceptable depression treatments until the last ten years, when light therapy has quickly approaching a substantial position of respectability for the treatment of depression.
In 2005, the American Psychiatric Association in Washington, D.C., had come to the conclusion that in trial experiments, a daily exposure to bright light which utilizes natural sunlight or Light Box Therapy. It is considered just as effective as any of the antidepressant drugs in the treatment of seasonal affective disorder (SAD) which is also called "winter depression", along with other forms of depression.
Over the past years, treatments such as the Light Box Therapy had been scoffed at by mainstream psychiatrists in the claims of "diminishing signs of depression" when exposed to daily bright-light exposures. These Light Box Therapy exposures ranged in early morning treatments from 30 minutes to one hour, with the trial results. When the tests were completed, they demonstrated pronounced and remarkable easing of the SAD symptoms upon awakening in the morning and apply dawn simulations of the Light Box Therapy or natural sunlight.
The latest research does not show yet results for severe depression, or whether certain colors can cause any eye problems or issues, even though there is a major agreement that it will not. And new treatments such as the Light Box Therapy combined with one night of sleep deprivation followed by a week's normal sleeping patterns, are increasing recovery for those who are presently receiving antidepressants for bipolar or major depressions. But the maximum of long-term benefits are achieved with Light Box Therapy or natural sunlight in addition to sleeping with a regular schedule in order to balance the biological clock.
Shorter days with less sunlight began around October 30, 2007, in certain areas--Alaska, Maine, Vermont, and some other northern U.S. states--right after daylight saving ended. Approximately 14.5 million Americans are diagnosed with SAD, with feelings of suicide, lack of interest in anything around them, extreme fatigue, or feelings of worthlessness. To many of them, the Light Box Therapy with either white light or a full spectrum light to simulate the sunlight, will offer them a better feeling--depending on where or not they can stick to it or not.
Some of the more recent treatments of SAD include the Light Box Therapy combined with cognital-behavioral therapy, or CBT, which has results in the high 80% range bracket. They also have been proven to show less depression after a one-year follow up than either treatment alone.
Fda Approved Light Therapy News
Therapy Lasers: Too Good to be True? - VetPracticeNews.com
Therapy Lasers: Too Good to be True? VetPracticeNews.com After years of inferior products and exaggerated claims, we must be specific and accurate with our statements. So this is not a discussion of “light” therapy but “laser” therapy. More specifically, we are talking mainly about high power laser therapy. |
In rare slap, FDA review rips up Pfizer's case for tafamidis - FierceBiotech
In rare slap, FDA review rips up Pfizer's case for tafamidis FierceBiotech Pfizer, though, plans to put its case on the drug in the best light possible. "There is currently no FDA-approved treatment designed specifically to treat TTR-FAP," Pfizer noted in a statement to FierceBiotech this morning. "If approved by the FDA, ... FDA staff not impressed with Pfizer rare disease drug tafamidis |
MedX Health Corp. Enters India - One of the World's Largest and Fastest ... - Stockhouse
MedX Health Corp. Enters India - One of the World's Largest and Fastest ... Stockhouse MDX) with worldwide revenues in drug free, non-invasive low level laser light therapy and light imaging systems, announced that their distribution partner in India, HealthX Lasers (www.healthxlasers.com), is working with hospitals, physicians, clinics, ... |
FDA staff backs J&J's Xarelto for heart condition - FierceBiotech
FDA staff backs J&J's Xarelto for heart condition FierceBiotech As Johnson & Johnson ($JNJ) builds the blockbuster pedigree of Xarelto, an FDA reviewer has given the thumbs-up to the new clot-busting drug as a treatment for the heart problem known as acute coronary syndrome. The staffers' recommendation of approval ... |
Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans - MarketWatch (press release)
Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans MarketWatch (press release) The P-IND -- part of a larger, coordinated research effort -- was submitted by the first test site at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, which includes patient enrollment at ... |